Malviya / Sundram | DNA- and m-RNA-Based Vaccines | Buch | 978-1-77491-960-6 | www.sack.de

Buch, Englisch, 302 Seiten, Format (B × H): 152 mm x 229 mm

Malviya / Sundram

DNA- and m-RNA-Based Vaccines

An Immunotherapeutic Approach to Cancer
1. Auflage 2025
ISBN: 978-1-77491-960-6
Verlag: Apple Academic Press Inc.

An Immunotherapeutic Approach to Cancer

Buch, Englisch, 302 Seiten, Format (B × H): 152 mm x 229 mm

ISBN: 978-1-77491-960-6
Verlag: Apple Academic Press Inc.


One of the most novel and promising strategies in medical research and the fight against cancer is the combination of DNA and messenger RNA vaccines. This new book explores the therapeutic uses, the biological processes, and the difficulties related to this novel strategy for cancer immunotherapy. Offering a unique perspective on different facets of DNA- and mRNA-based cancer vaccines, the authors present a thorough overview of the constantly changing field of cancer immunotherapy, from explaining the unique aspects of tumor angiogenesis and the role that non-coding RNAs play in treatment resistance, to investigating the most recent developments in gene therapy and splicing control. The volume also looks at this fascinating field’s future potential, giving cancer patients hope for less intrusive and more effective therapies.

Malviya / Sundram DNA- and m-RNA-Based Vaccines jetzt bestellen!

Zielgruppe


Academic and Postgraduate

Weitere Infos & Material


Foreword Preface 1. Various Prospects of Tumor Angiogenesis 2. Cancer Treatment Through Gene Therapy: Methods, Challenges, and Current Progress 3. Current Status and Prospects for Cancer Gene Therapy 4. Therapeutic Interventions and Non-Coding RNA-Mediated Mechanisms of Cancer Resistance 5. The Role of Splicing as a Therapeutic Target of Cancer 6. Cancer DNA Vaccines: Inducing Efficient Immunity 7. Innovative DNA Vaccines That Utilize Pinpoint Precision Technology to Effectively Stimulate the Immune System Against Cancer 8. Utilizing DNA Vaccines and Electroporation to Fight Cancer 9. Promoting DNA-Based Cancer Vaccine Research 10. Cancer Immunotherapy Using a DNA Vaccination 11. Cancer Vaccine Based on Plasmid DNA and Messenger RNA


Sonali Sundram, MPharm, is an Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, India. She was previously affiliated as a research scientist with the Indian Council of Medical Research at King George’s Medical University and with S Babu Banarasi Das Northern India Institute of Technology, both in India. Her PhD (Pharmacy) work is in neurodegeneration and nanoformulation. Her areas of interest include neurodegeneration, clinical research, and artificial intelligence. She has edited several books and has organized more than 15 national and international seminars, conferences, and workshops. She has more than eight patents, both national and international, to her credit.

Rishabha Malviya, PhD, has 15 years of research experience. He is a Professor of Pharmacy, School of Medical and Allied Sciences, Galgotias University, India. His areas of interest include formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery, and characterization of natural polymers as pharmaceutical excipients. He has authored more than 300 research and review papers for national and international journals and has 58 patents to his name. He has also published edited books and authored 170 book chapters. He is included in the list of the World’s Top 2% Scientists (2020, 2021, 2022, 2023 and 2024) by Elsevier BV and Stanford University. He is reviewer, editor, and editorial board member for more than 50 national and international journals.



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.